Premium
AUTOLOGOUS STEM CELL TRANSPLANTATION MAY POTENTIALLY ABROGATE THE NEGATIVE PROGNOSTIC EFFECT OF EARLY RELAPSE AFTER CHEMO OR INMUNOCHEMOTHERAPY IN FOLLICULAR LYMPHOMA
Author(s) -
Jiménez Ubieto A.,
Grande C.,
Caballero D.,
Yañez L.,
Novelli S.,
HernándezGarcia M.,
Manzanares M.,
Arranz R.,
Ferreiro J.,
Bobillo S.,
Mercadal S.,
Galego A.,
LópezJiménez J.,
Moraleda J.,
Vallejo C.,
Albo C.,
PérezCeballos E.,
Marrero C.,
Magnano L.,
Palomera L.,
Jarque I.,
Martín A.,
Coria E.,
LópezGuillermo A.,
Salar A.,
Lahuerta J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_85
Subject(s) - medicine , rituximab , autologous stem cell transplantation , follicular lymphoma , international prognostic index , regimen , transplantation , oncology , surgery , lymphoma , induction chemotherapy , progression free survival , chemotherapy